Guidelines for the management of anaphylaxis in children and adolescents

  • Tina Vesel Služba za alergologijo, revmatologijo in klinično imunologijo, Pediatrična klinika, Univerzitetni klinični center Ljubljana, Bohoričeva 20, 1000 Ljubljana
  • Anja Koren Jeverica Služba za alergologijo, revmatologijo in klinično imunologijo, Pediatrična klinika, Univerzitetni klinični center Ljubljana, Bohoričeva 20, 1000 Ljubljana
  • Nina Emeršič Služba za alergologijo, revmatologijo in klinično imunologijo, Pediatrična klinika, Univerzitetni klinični center Ljubljana, Bohoričeva 20, 1000 Ljubljana
  • Tanja Loboda Pediatrična služba, Splošna bolnišnica Jesenice, Cesta maršala Tita 112, 4270 Jesenice
  • Meta Accetto Služba za alergologijo, revmatologijo in klinično imunologijo, Pediatrična klinika, Univerzitetni klinični center Ljubljana, Bohoričeva 20, 1000 Ljubljana
  • Ruben Bizjak Pediatrična služba, Splošna bolnišnica »dr. Franca Derganca« Nova Gorica, Ulica padlih borcev 13A, 5290 Šempeter pri Gorici
  • Andreja Obermayer-Temlin Otroški oddelek, Splošna bolnišnica Celje, Oblakova ulica 5, 3000 Celje
  • Matjaž Homšak Klinika za pediatrijo, Univerzitetni klinični center Maribor, Ljubljanska ulica 5, 2000 Maribor
  • Vojko Berce Klinika za pediatrijo, Univerzitetni klinični center Maribor, Ljubljanska ulica 5, 2000 Maribor
  • Mitja Košnik Univerzitetna klinika za pljučne bolezni in alergijo Golnik, Golnik 36, 4204 Golnik
  • Tadej Avčin Služba za alergologijo, revmatologijo in klinično imunologijo, Pediatrična klinika, Univerzitetni klinični center Ljubljana, Bohoričeva 20, 1000 Ljubljana
Keywords: anaphylaxis, children, treatment, adrenaline, adrenaline auto-injector

Abstract

Anaphylaxis is a severe life-threatening generalized or systemic hypersensitivity reaction. All doctors and other medical staff should be familiar with the treatment of anaphylaxis. Food, insect bites and drugs and are principal agents responsible for anaphylaxis in children and adolescents. In the absence of treatment, the reaction may rapidly progress with severe manifestations including fatal outcome. Intramuscular adrenaline is first-line therapy for anaphylaxis. Additional measures, such as removing the trigger, call for help, the correct position of the child or adolescent, high-flow oxygen, volume support, bronchodilator and adrenaline inhalations, systemic antihistamine and glucocorticoid, are supplementary to adrenaline. At discharge from hospital it is necessary to assess the risk of future anaphylaxis to determine the individualized management plan in case of anaphylaxis and to prescribe adrenaline auto-injector. Training of the child, parents and others who take care of the child, on when and how to use the self-injectable devices of adrenaline is necessary. Allergy assessment at an allergists office is obligatory in all children with a history of anaphylaxis in order to determine the cause of anaphylaxis, to provide detailed instructions on allergen avoidance and, if possible, to start with specific immunotherapy.

Downloads

Download data is not yet available.

References

Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier B, Lockey R, et al. A revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of World Allergy Organization. J Allergy Clin Immunol 2004; 113: 832–6.

Bohlke K, Davis RL, De Stefano F, Mary SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004; 113: 536–42.

Braganza SC, Acworth JP, Mckinnon DR, Peake JE, Brown AF. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006; 91: 159–63.

Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child 2002; 86: 236–9.

Novembre E, Cianferoni A, Bernardini R, Mugnaini L, Caffarelli C, Cavagni G, et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics 1998; 101: 8–16.

Bock SA, Munoz-Furlong A, Sampson HA. Fatalities dues to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107: 191–3.

Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children – a questionnaire based survey in Germany. Allergy 2005; 60: 1440–5.

Lin RY, Anderson AS, Shah SN, Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990–2006. Ann Allergy Asthma Immunol 2008; 101: 387–93.

Cardona V, Luengo 0, Garriga T, Labrador-Horrillo M, Sala-Cunill A, Izquierdo A, et al. Co-factor-enhaced food allergy. Allergy 2012; 67: 1316–8.

Horny HP, Sotlar K, Valent P. Mastocytosis: state of the art. Pathobiology 2007; 74: 121–32.

Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxis. Blood 2007; 110: 2331–3.

Guglielmi L, Fontaine C, Gougat C, Avinens O, Eliaou JF, Guglielmi P, et al. IL-10 promoter and IL4-Ralpha gene SNPs are associated with immediate beta-lactam allergy in atopic women. Allergy 2006; 61: 921–7.

Beyer K, Eckmann O, Hompes S, Grabenhenrich L, Worm M. Anaphylaxis in an emergency setting- elicitors, therapy and incidence of severe allergic reactions. Allergy 2012; 67: 1451–6.

Pouessel G, Deschildre A, Castelain C, Sardet A, Sagot-Bevenot S, De Sauve-Boeuf A, et al. Parental knowledge and use of epinephrine auto-injector for children with food allergy. Pediatr Allergy Immunol 2006; 17: 221–6.

Alergološka imunološka sekcija SZD, Bolnišnica Golnik, Dermatološka klinika, Pediatrična klinika, Sekcija za intenzivno medicino SZD, Združenje za intenzivno medicino in SZD, et al. Zdravljenje anafilaksije- strokovna izhodišča. Zdrav Vestn 2002; 71: 479–81.

Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. EAACI Task Force on Anaphylaxis in Children. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 62: 857–71.

Anaphylaxis: Guidelines from the Europen Academy of Allergy and Clinical Immunology. Dosegljivo na: http://www.eaaci.org/attachments/Anaphylaxis guidelines Draft 4.5 2013 06. pdf

Simons FER, Ardusso LRF, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World anaphylaxis guidelines: Summary J Allergy Clin Immunol 2011; 127; 587–93.

Fukuoka Y, Xia HZ, Sanchez-Munoz LB, Dellinger AL, Escribano L, Schwartz LB. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. J Immunol 2008; 180: 6307–16.

Brunnee T, Reddigari SR, Shibayama Y, Kaplan AP, Silverberg M. Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions. Clin Exp Allergy 1997; 27: 653–63.

Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P. Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 2006; 116: 2244–51.

Triggiani M, Patella V, Staiano RI, Granata F, Marone G. Allergy and the cardiovascular system. Clin Exp Immunol 2008; 153 Suppl 1: 7–11.

Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A et al. Second symposium on the definition management of anaphylaxis: summary report-Second National Institute of and Infectious Disease/Food Allergy Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391–7.

Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005; 5: 359–64.

Sala-Cunill A, Cardona V, Labrador-Horrillo M, Luengo O, Esteso O, Garriga T, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol 2013; 160: 192–9.

Mehr S, Liew WK, Tey D, Tang ML. Clinical predictors for biphasic reactions in children presenting with anaphylaxis. Clin Exp Allergy 2009; 39: 1390–6.

Golden DB. Patterns of anaphylaxis: acute and late phase features of allergic reactions. Novartis Found Symp 2004; 257: 101–10.

Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144–50.

Simons FE, Clark S, Camargo CA, Jr. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 2009; 124: 301–6.

Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004; 113: 837–44.

Nolan J, Baskett P. ERC Guidelines for Resuscitation 2005. Oxford: Elsevier, 2005.

Gu X, Simons FE, Simons KJ. Epinephrine absorption after different routes of administration in an animal model. Biopharm Drug Dispos 1999; 20: 401–5.

Järvinen KM, Sicherer SH, Samson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol 2008; 122: 133–8.

Gueugniaud PY, David JS, Chanzy E, Hubert T, Dubien PJ, Mauriancourt P, e tal. Vasopressin and epinephrine vs. Epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 2008; 359; 21–30.

Sheikh A, Ten Broek V, Brown S, Simons F. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2007; CD006160.

Vesel T, Šilar M, Accetto M, Uroš Krivec, Simona Žitnik, Vesna Glavnik, et al. Hypersensitivity to glucocorticoids in children. In: Polič B, ed. Abstact book of 2nd Meeting of Middle-European Societies for Immunology and Allergology. 2013 Okt 10–13; Opatija, Hrvaška. Opatija; 2013.

Zaloga G, Delacey W, Holmboe E, Chernow B. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Int Med 1986; 105: 65–6.

Javeed N, Javeed H, Javeed S, Moussa G, Wong P, Rezai F. Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn 1996; 39: 383–4.

Sheth SS, Waserman S, Kagan R, Alizadehfar R, Primeau MN, Elliot S, et al. Role of food labels in accidental exposures in food-allergic individuals in Canada. Ann Allergy Asthma Immunol 2010; 104: 60–5.

Moffitt JE, Golden DB, Reisman RE, Lee R, Nicklas R, Freeman T, et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol 2004; 114: 869–86.

Noimark L, Wales J, Du Toit G, Pastacaldi C, Haddad D, Gardner J, et al. The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy 2012; 42: 284–92.

Campbell RL, Luke A, Weaver AL, St Sauver JL, Bergstralh EJ, Li JT, et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol 2008; 101: 631–6.

Ben Shoshan M, Kagan R, Primeau MN, Alizadehfar R, Verreault N, Yu JW, et al. Availability of the epinephrine autoinjector at school in children with peanut allergy. Ann Allergy Asthma Immunol 2008; 100: 570–5.

How to Cite
1.
Vesel T, Koren Jeverica A, Emeršič N, Loboda T, Accetto M, Bizjak R, Obermayer-Temlin A, Homšak M, Berce V, Košnik M, Avčin T. Guidelines for the management of anaphylaxis in children and adolescents. TEST ZdravVestn [Internet]. 1 [cited 1May2024];83(6). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/1242
Issue
Vol 83 No 6 (2014): June
Section
Quality and safety


The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.